Evidence map›Paper›PMID 37589443›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

The First Population-Level Description of Women Diagnosed With Invasive Breast Cancer in Costa Rica From 2008 to 2012: A Cross-Sectional Study.

Amada Aparicio, Percy Guzman, Melvin Morera, Yoleni Calvo, Marjorie Obando, Denis Landaverde, Ileana González, Esmeralda Ramirez-Pena

Open access · goldAbstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Amada AparicioCosta Rica Social Security Fund, San Jose, Costa Rica.
Percy GuzmanCancer Prevention Fellowship Program (CPFP), Division of Cancer Prevention (DCP), National Cancer Institute (NCI), Bethesda, MD, USA.ORCID 0000-0002-7955-3841
Melvin MoreraCosta Rica Social Security Fund, San Jose, Costa Rica.
Yoleni CalvoCosta Rica Social Security Fund, San Jose, Costa Rica.
Marjorie ObandoCosta Rica Social Security Fund, San Jose, Costa Rica.
Denis LandaverdeCosta Rica Social Security Fund, San Jose, Costa Rica.
Ileana GonzálezCosta Rica Social Security Fund, San Jose, Costa Rica.
Esmeralda Ramirez-PenaCancer Prevention Fellowship Program (CPFP), Division of Cancer Prevention (DCP), National Cancer Institute (NCI), Bethesda, MD, USA.
Costa Rican Department of Social Security · CRNational Cancer Institute · USUnited States Department of Health and Human Services · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBreast cancer is the leading cause of cancer-related deaths among women worldwide. In Costa Rica, it ranks first in incidence and fourth in terms of mortality. However, there is a lack of comprehensive information on treatment patterns and outcomes for breast cancer patients in Costa Rica.

methodsThis study utilized data from the National Tumor Registry, which was merged with the Costa Rica Social Security Fund (CCSS) to ensure comprehensive access to clinical information. The study is prospective and focused on patients diagnosed with breast cancer between January 2008 and December 2012. This combined dataset allowed for a more comprehensive analysis of patient characteristics, treatment patterns, and outcomes related to breast cancer in Costa Rica.

resultsAmong the 4775 patients diagnosed during this period, 3160 met the inclusion criteria for our study. The average age at diagnosis was 59.1 years, with 32.5% of patients being over the age of 65. Most of the patients (55.4%) identified themselves as homemakers, while 46.5% underwent core needle biopsy for diagnosis. Approximately 60% of women were diagnosed with early-stage disease (IA, IIA, and IIB), while 1.7% had metastatic disease, mainly affecting the bone. The mean interval between diagnosis and surgery was 72 days. Most patients (88.7%) received surgery as their initial treatment, and over half (54.4%) received some form of adjuvant therapy. Additionally, 85.6% of patients completed their prescribed treatment.

conclusionThis study provides a comprehensive and detailed description of the characteristics and treatment patterns among breast cancer patients in Costa Rica. The findings contribute to our understanding of the disease in this population and can serve as a foundation for further research and improvement in breast cancer management and care.

Indexed as

Breast NeoplasmsNeoplasms, Second PrimaryCosta RicaCross-Sectional StudiesFemaleHumansMiddle AgedProspective Studiescancerincidencemortality

Identifiers

PMID37589443
PMCPMC10437208
OpenAlexW4385898478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.